Log in to search using one of your social media accounts:

 

Cochrane Skin Group celebrate 20 years of improving treatment of skin diseases

World-leading dermatologists and their patients are celebrating huge improvements in the treatment of skin diseases like skin cancer, psoriasis, and acne as theCochrane Skin Group marks its 20th anniversary this week.   The effects of the 120 plus published Cochrane Skin Reviews have been far-reaching and have had real impacts on patient care. These include skin cancer, skin allergies, and acne, blistering diseases, hair disorders like alopecia, fungal infections and psoriasis as well as tropical parasitic disea ses.The group is coordinated by the University of Nottingham ’s Centre of Evidence Based Dermatology and is part of the global Cochrane network that carries out systematic reviews of primary research covering all areas of health and health policy. Cochrane is internationally recognised as setting the highest standards in evidence-based health care resources .The effects of the 120 plus published Cochrane Skin Reviews have been far-reaching and have had real impacts on patient care. These include skin cancer, skin allergies and acne, blistering diseases, hair disorders like alopecia, fungal infections and psoriasis as well as tropical parasitic diseases.“By systematically reviewing and summarising all relevant clinical trials, Cochrane Skin tries to drive up the quality of primary research into skin disease prevention and treatments,” says Professor Hywel Williams, the visionary founder of Cochrane Skin. “A lot of dermatology clinical trial...
Source: Cochrane News and Events - Category: Information Technology Authors: Source Type: news

Related Links:

LONDON (Reuters) - Bristol-Myers Squibb's immunotherapy drug Opdivo has been recommended for some patients with lung cancer by Britain's healthcare cost watchdog NICE after the drugmaker agreed a discounted price.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
This study considered 73 patients 
Source: Pediatric Blood and Cancer - Category: Cancer & Oncology Authors: Tags: RESEARCH ARTICLE Source Type: research
Date: Wednesday, 10 18, 2017; Speaker: Jorge Carrasquillo, MD Per Diem Physician Consultant, , Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan , Kettering Cancer Center, NY; Professor of Rad, ; Building: Building 10 (Clinical Center); Lipsett Amphitheater; CME Credit; Videocast Event
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Monday, 10 23, 2017; Speaker: Angelika Amon, Ph.D., Professor, David H. Koch Institute , Massachusetts Institute of Technology; Building: Building 10 (Clinical Center); Lipsett Amphitheater; CME Credit
Source: NIH Calendar of Events - Category: American Health Source Type: events
In conclusion, we have uncovered that LINC00968 could be regarded as a novel prognostic biomarker and therapeutic target in NSCLC diagnosis and treatment. This article is protected by copyright. All rights reserved
Source: Journal of Cellular Physiology - Category: Cytology Authors: Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
No one ever believes that Sarah Manning Norton, 47 from Massachusetts, (pictured, right with her husband, Bill) is telling the truth about her allergy, but her attacks started when she was just 17.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Metallic tastes can appear for many patients on chemo
Source: The Doctors Lounge - Psychiatry - Category: Psychiatry Tags: Neurology, Nursing, Oncology, Pharmacy, Psychiatry, Nutrition, News, Source Type: news
Then new organization intends to spearhead innovations in the cure for Prostate Cancer
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
A Glendale-based charity is donating $2.7 million to Cincinnati Children ’s Hospital to create an international consortium that will collaborate on clinical trials of promising medications for children with high-risk brain tumors. This afternoon the Cure Starts Now planned to surprise Dr. Maryam Fouladi, medical director of the Brain Tumor Center at Cincinnati Childre n’s, with a check for $1.5 million, which represents the first two years of funding for the three-year grant. The check was to…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
This study aimed to investigate the effect of black seed oil on imiquimod (IMQ) induced psoriasis‐like skin lesions. To this end, 30 male albino rats were divided into three groups: group I, control group; group II, psoriasis‐induced group receiving daily topical applications of IMQ cream (5%) on the shaved back skin for 10 consecutive days; and group III, black seed oil group receiving a daily topical dose of black seed oil 5 mg/kg body weight for 10 days after induction of psoriasis. Animals of all groups were sacrificed and specimens obtained from the skin of the central part of the back were processed for histologi...
Source: The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology - Category: Molecular Biology Authors: Tags: Full Length Article Source Type: research
More News: Acne | African Health | Allergy | Allergy & Immunology | Alopecia | Blogging | Cancer | Cancer & Oncology | Child Development | Childhood Cancer | Clinical Trials | Dermatology | France Health | Fungal Infections | Grants | Health Management | Information Technology | National Institute for Health Research (NIHR) | Parasitic Diseases | Parasitology | Psoriasis | Psychology | Skin | Skin Cancer | South Africa Health | Study | UK Health | Vitiligo | Wheat